Search

… led the study under the scientific leadership of Pawel Kalinski, MD, PhD, senior author of the paper, Chair of … Cancer Institute and U.S. Department of Defense, Dr. Kalinski directed earlier preclinical studies demonstrating … an easy-to-apply, short-term systemic treatment,” says Dr. Kalinski. CKM also may hold promise for treating other types …

… development at Roswell Park under the leadership of Pawel Kalinski, MD, PhD, involving modulation of key proteins known … to immunotherapy and other forms of cancer treatment. Dr. Kalinski, Chair of the Department of Immunology and Chief of … development at Roswell Park under the leadership of Pawel Kalinski, MD, PhD, involving modulation of key proteins known …

… increases the risk of immune-related adverse events. Pawel Kalinski, MD, PhD , Professor of Immunology at Roswell Park, … increases the risk of immune-related adverse events. Pawel Kalinski, MD, PhD , Professor of Immunology at Roswell Park, …

… development at Roswell Park under the leadership of Pawel Kalinski, MD, PhD, involving modulation of key proteins known … development at Roswell Park under the leadership of Pawel Kalinski, MD, PhD, involving modulation of key proteins known …

… in Hall A   Shipra Gandhi, MD, is first author and Pawel Kalinski, PhD , is senior author on “ Phase IIa study of αDC1 … in Hall A   Shipra Gandhi, MD, is first author and Pawel Kalinski, PhD , is senior author on “ Phase IIa study of αDC1 …

… trainee in Immunology, is first author and Pawel Kalinski, MD, PhD, Chair of Immunology, is senior author on  … trainee in Immunology, is first author and Pawel Kalinski, MD, PhD, Chair of Immunology, is senior author on  …